- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Sodium phenylbutyrate – November 2017
Sodium phenylbutyrate: Granules for oral suspension 483 mg (as sodium) per g, 174 g; Pheburane®
Last updated
16 March 2018